News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Torax Medical Wins Panel Backing From FDA on Acid Reflux Device



1/13/2012 6:44:06 AM

SHOREVIEW, Minn.--(BUSINESS WIRE)--The LINX® Reflux Management System, a novel device for the treatment of Gastroesophageal Reflux Disease (GERD), has received a positive recommendation from the Food and Drug Administration’s (FDA) Gastroenterology and Urology Devices Advisory Panel.

The FDA advisory panel unanimously voted yes to all three questions posed by the FDA, affirming efficacy, safety and risk-benefit ratio for the LINX® Reflux Management System. The advisory panel meeting was the most recent milestone in the FDA regulatory review process for Torax Medical.

“Torax Medical is very pleased that the Gastroenterology and Urology Devices Advisory Panel recognized the clinical benefits of the LINX System. We look forward to working with the FDA to reach a final decision on approval to make the LINX treatment available to patients in the United States,” commented Todd Berg, chief executive officer of Torax Medical.

The LINX Device

The LINX Reflux Management System incorporates a small flexible band of interlinked titanium beads with magnetic cores, which is laparoscopically placed around the esophageal sphincter. The magnetic attraction between the beads is intended to help the sphincter resist opening to gastric pressure, preventing reflux from the stomach into the esophagus. Higher pressures from swallowing can overcome the magnetic forces, allowing food and liquid to pass normally into the stomach.

About Torax Medical

Torax Medical Inc. is a privately held medical device company headquartered in St. Paul, Minnesota that develops and markets products designed to treat sphincter disorders. Torax Medical’s technology platform, Magnetic Sphincter Augmentation (MSA), is currently marketed in Europe as the LINX® Reflux Management System for the treatment of Gastroesophageal Reflux Disease (GERD) and the FENIX™ Continence Restoration System for the treatment of Fecal Incontinence (FI). In the United States, the LINX System is not approved for commercial distribution and is currently limited by Federal law to investigational use. For more information, please visit www.toraxmedical.com.

Contact:

Torax Medical, Inc.

Colleen Simcoe, 651-361-8900


Read at BioSpace.com
Read at WebMD


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES